Search by Drug Name or NDC

NDC 00456-3200-14 Namenda Details

Namenda

Namenda is a ORAL KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is .

MedlinePlus Drug Summary

Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember or may slow the loss of these abilities in people who have AD. However, memantine will not cure AD or prevent the loss of these abilities at some time in the future.

Related Packages: 00456-3200-14
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Memantine

Product Information

NDC	00456-3200
Product ID	0456-3200_8bb8ac09-8fd2-4cb6-bad0-bc4f9b48a708
Associated GPIs	62053550100350
GCN Sequence Number	053325
GCN Sequence Number Description	memantine HCl TAB DS PK 5 MG-10 MG ORAL
HIC3	H1A
HIC3 Description	ALZHEIMER'S THERAPY, NMDA RECEPTOR ANTAGONISTS
GCN	20774
HICL Sequence Number	013778
HICL Sequence Number Description	MEMANTINE HCL
Brand/Generic	Brand
Proprietary Name	Namenda
Proprietary Name Suffix	n/a
Non-Proprietary Name	Memantine Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	KIT
Route	ORAL
Active Ingredient Strength	n/a
Active Ingredient Units	n/a
Substance Name	n/a
Labeler Name	Allergan, Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021487
Listing Certified Through	2024-12-31

Package

NDC 00456-3200-14 (00456320014)

Pricing Information	N/A
NDC Package Code	0456-3200-14
Billing NDC	00456320014
Package	1 KIT in 1 BLISTER PACK (0456-3200-14)
Marketing Start Date	2003-10-16
NDC Exclude Flag	N